Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study

Recent large clinical trials have demonstrated cardiovascular benefits of similar overall magnitude for sodium –glucose cotransporter-2 inhibitor (SGLT-2i) and glucagon-like peptide-1 receptor agonist (GLP-1RA)...

Source: Cardiovascular Diabetology - June 28, 2023 Category: Cardiology Authors: Minji Sohn, Johannes W. Dietrich, Michael A. Nauck and Soo Lim Tags: Research Source Type: research